Kanis JA - Search Results

1

Risk of hip fracture derived from relative risks: an analysis applied to the population of Sweden.

Kanis JA, Johnell O, Oden A, Jonsson B, Dawson A, Dere W. Kanis JA, et al. Osteoporos Int. 2000;11(2):120-7. doi: 10.1007/PL00004173. Osteoporos Int. 2000. PMID: 10793869

2

The apparent incidence of hip fracture in Europe: a study of national register sources.

Johnell O, Gullberg B, Allander E, Kanis JA; MEDOS Study Group. Johnell O, et al. Among authors: kanis ja. Osteoporos Int. 1992 Nov;2(6):298-302. doi: 10.1007/BF01623186. Osteoporos Int. 1992. PMID: 1421798

3

Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture.

Kanis JA, Johnell O, Gullberg B, Allander E, Dilşen G, Gennari C, Lopes Vaz AA, Lyritis GP, Mazzuoli G, Miravet L, et al. Kanis JA, et al. BMJ. 1992 Nov 7;305(6862):1124-8. doi: 10.1136/bmj.305.6862.1124. BMJ. 1992. PMID: 1463947 Free PMC article.

4

The variable incidence of hip fracture in southern Europe: the MEDOS Study.

Elffors I, Allander E, Kanis JA, Gullberg B, Johnell O, Dequeker J, Dilsen G, Gennari C, Lopes Vaz AA, Lyritis G, et al. Elffors I, et al. Among authors: kanis ja. Osteoporos Int. 1994 Sep;4(5):253-63. doi: 10.1007/BF01623349. Osteoporos Int. 1994. PMID: 7812073

5

Methodology of MEDOS multicentre study of hip fracture incidence: validity and relevance considerations.

Elffors L, Gullberg B, Allander E, Johnell O, Kanis JA. Elffors L, et al. Among authors: kanis ja. Bone. 1993;14 Suppl 1:S45-9. doi: 10.1016/8756-3282(93)90349-f. Bone. 1993. PMID: 8110520

6

Therapeutic strategies in the prevention of hip fracture with drugs affecting bone metabolism.

Johnell O, Stenbeck M, Rosen M, Gullberg B, Kanis JA. Johnell O, et al. Among authors: kanis ja. Bone. 1993;14 Suppl 1:S85-7. doi: 10.1016/8756-3282(93)90357-g. Bone. 1993. PMID: 8110528

7

The assessment of vertebral deformity: a method for use in population studies and clinical trials.

McCloskey EV, Spector TD, Eyres KS, Fern ED, O'Rourke N, Vasikaran S, Kanis JA. McCloskey EV, et al. Among authors: kanis ja. Osteoporos Int. 1993 May;3(3):138-47. doi: 10.1007/BF01623275. Osteoporos Int. 1993. PMID: 8481590

8

Rationale for the use of clodronate in osteoporosis.

Kanis JA, McCloskey EV, Sirtori P, Khan S, Fern D, Eyres K, Aaron J, Beneton MN. Kanis JA, et al. Osteoporos Int. 1993;3 Suppl 2:S23-8. doi: 10.1007/BF01623223. Osteoporos Int. 1993. PMID: 8481595 Review.

9

Risk factors for hip fracture in European women: the MEDOS Study. Mediterranean Osteoporosis Study.

Johnell O, Gullberg B, Kanis JA, Allander E, Elffors L, Dequeker J, Dilsen G, Gennari C, Lopes Vaz A, Lyritis G, et al. Johnell O, et al. Among authors: kanis ja. J Bone Miner Res. 1995 Nov;10(11):1802-15. doi: 10.1002/jbmr.5650101125. J Bone Miner Res. 1995. PMID: 8592959

10

Evaluation of the risk of hip fracture.

Kanis JA, McCloskey EV. Kanis JA, et al. Bone. 1996 Mar;18(3 Suppl):127S-132S. doi: 10.1016/8756-3282(95)00493-9. Bone. 1996. PMID: 8777077 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

874 results

Search Page

Filters